Position
Squarepoint Ops LLC in MBX Biosciences, Inc.
Back to the book · All holders of MBX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$78.9K$31.54 → $29.85
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 46.7K | $1.47M | — | — | — | 0.0% |
| Q1 2026 | 97.2K | $2.9M | $29.85 | −$78.9K | $1.51M | 0.0% |